Position in ABBV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$924,115
-$46,739 QoQ
Shares Held
4,249
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SMITH CHAS P & ASSOCIATES PA CPAS holds $179,997,284 across 8 Drug Manufacturers - General names. ABBV ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
251,939 | $61,583,969 | |
| 2 | MRK |
Merck & Co., Inc.
|
367,523 | $44,209,341 | |
| 3 | AMGN |
Amgen Inc
|
118,985 | $41,864,872 | |
| 4 | NVO |
Novo Nordisk A S
|
801,586 | $29,458,285 | |
| 5 | LLY |
ELI LILLY & Co
|
1,254 | $1,153,391 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
4,249 | $924,115 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,023 | $425,944 | |
| 8 | PFE |
Pfizer Inc
|
13,439 | $377,367 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $924,115 | 4,249 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $970,854 | 4,249 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $729,119 | 3,149 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $804,477 | 4,334 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $928,802 | 4,433 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $816,176 | 4,593 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $907,025 | 4,593 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $764,464 | 4,457 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $815,808 | 4,480 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $538,830 | 3,477 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $513,958 | 3,448 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $711,509 | 5,281 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $734,855 | 4,611 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $766,677 | 4,744 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $677,894 | 5,051 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $779,737 | 5,091 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $978,820 | 6,038 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $817,139 | 6,035 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $622,841 | 5,774 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $672,911 | 5,974 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $615,014 | 5,683 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $608,933 | 5,683 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $496,109 | 5,664 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $598,898 | 6,100 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $494,701 | 6,493 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||